Navigation Links
Luminex Corporation To Present At Upcoming Investment Conferences In September
Date:9/12/2012

AUSTIN, Texas, Sept. 12, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that management will present at two upcoming investment conferences, the UBS Global Life Sciences Conference and the Credit Suisse 2012 Small & Mid Cap Conference, both scheduled to take place in New York City.  

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

Patrick J. Balthrop, president and chief executive officer, will present at the UBS Global Life Sciences Conference on September 19, 2012 at 1 p.m. Eastern time, and at the Credit Suisse 2012 Small & Mid Cap Conference on September 21, 2012 at 1:10 p.m. Eastern time.

The presentations will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. We are transforming global healthcare and life-science research through the development, manufacturing, and marketing of proprietary instruments and assays utilizing our xMAP® open-architecture, multi-analyte platform and our MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies that deliver cost-effective and rapid results to clinicians and researchers. Our technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies.  We are meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.  For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology please visit our website at http://www.luminexcorp.com.

 Contacts:

Harriss T. CurrieVice President, Finance and Chief Financial Officer512-219-8020Matthew ScaloSr. Director of Investor Relations512-219-8020mscalo@luminexcorp.com


'/>"/>
SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
2. Luminex Corporation Recognized as Best Technology Company in Austin
3. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
4. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
5. Luminex Corporation Reports Second Quarter 2012 Results
6. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
7. Luminex Corporation Announces Agreement to Acquire GenturaDx
8. Luminex Corporation Reports First Quarter 2012 Results
9. Genelex Corporation Rolls Out Lifesaving DNA Healthcare System
10. Tranzbyte Corporation Acquires the Exclusive Right to Market Low-Cost, Innovative MRI machines in North and South America
11. American Pacific Corporation Completes Redemption Of $40 Million Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
(Date:9/12/2017)...  Consumer reviews on the independent review site Consumer Affairs ... company for hearing aids, ranking it higher than Miracle Ear ... ... For Hearing Aids ... online store that provides high performance, state-of-the-art, German-engineered hearing aids directly ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):